VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ all adult patients with a nasal or facial          │ all adult patients with a nasal or facial          │     100 │
│ skin/soft tissue defect requiring reconstruction   │ skin/soft tissue defect requiring reconstruction   │         │
│ limited to or including a full-thickness skin      │ limited to or including a full-thickness skin      │         │
│ graft                                              │ graft                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ current or recent (within one week of surgery)     │ current or recent (within one week of surgery)     │     100 │
│ systemic antibiotic use, intolerance to both       │ systemic antibiotic use, intolerance to both       │         │
│ clindamycin and cephalexin, discovery of a         │ clindamycin and cephalexin, discovery of a         │         │
│ persistent cutaneous malignancy at the site of the │ persistent cutaneous malignancy at the site of the │         │
│ defect following the reconstructive procedure and  │ defect following the reconstructive procedure and  │         │
│ previous reconstruction at the site of the         │ previous reconstruction at the site of the         │         │
│ skin/soft-tissue defect                            │ skin/soft-tissue defect                            │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                    │   Score │
╞═══════════════════════════════════╪══════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ all adult patients with a nasal or facial        │      22 │
│                                   │ skin/soft tissue defect requiring reconstruction │         │
│                                   │ limited to or including a full-thickness skin    │         │
│                                   │ graft                                            │         │
╘═══════════════════════════════════╧══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 96
Average Levenshtein Ratio of individual lines: 74.0
OverAll Ratio: 85.0
